The rate of cerebrovascular events in TAVR hovers about 4% in most of the current studies, regardless the center, the operator or the prosthetic valve. At present, no scores can adequately predict which patients run the highest risk of stroke during TAVR, and the routine use of cerebral protection devices remains controversial. The SENTINEL study...
Coronary Disease Works as a 30-Day Predictor in TAVR
The association between aortic stenosis and coronary disease is common, since both conditions share pathogenesis, risk factors, and symptoms. Transcatheter aortic valve replacement (TAVR) is currently indicated for high-risk and inoperable patients. It also appears as a valid alternative for the treatment of intermediate-risk patients, and it could soon be indicated for low-risk patients. Coronary...
Important Study Suggests that Rotational Atherectomy Is Feasible with Transradial Access
Rotational atherectomy is a very important tool in the treatment of heavily calcified and non-dilatable lesions. Historically, transfemoral access has been the gold standard due to a perceived need for large-bore guidewire catheters in order to use spheroids for proper debulking. Nowadays, rotational atherectomy has evolved towards a technique that aims to modify plaque for...
Complex PCI: DAPT defining factor?
Courtesy of Dr. Alejandro Lakowsky, MTSAC. The Journal of the American College of Cardiology (JACC) has recently published a study on the role of coronary anatomy and PCI technical difficulty in the cost benefit ratio of prolonged vs. short post procedural DAPT. This study was carried out by Robert Yeh, Laura Mauri and the DAPT trial...
Endarterectomy vs. Stenting in Asymptomatic Carotid Artery Stenosis
The comparative efficacy and safety of carotid stenting vs. endarterectomy in asymptomatic carotid stenosis patients remains controversial and, what is worse, consensus seems unlikely in the near future. Given the lack of definite evidence, several meta-analyzis and systematic reviews have been produced in an attempt to shed some light on this matter. This study included all...
These Are the Thrombosis Predictors for Absorb Bioresorbable Scaffolds
J Am Coll Cardiol Intv has recently published a special issue on bioresorbable scaffolds. Abbott’s decision to pull Absorb off the market probably prompted the fast publishing of all related articles sent to the journal. Bioresorbable scaffolds were developed in hopes that they would reduce the rates of events per year 1 year post-implantation by 1.5%-3%...
The work of a doctor in the catastrophe: anonymous testimony after the earthquakes in Mexico
The following is the anonymous testimony of a professional living in Mexico City who was directly affected by the earthquake on September 19. How to work in the middle of tragedy, professional responsibility and what feelings a doctor is going through in situations like this. “While we still had not recovered from the earthquake...
Should We Begin to Use IVUS in CTO?
Courtesy of Dr. Carlos Fava. Currently, chronic total occlusions (CTO) are one of the obstacles that coronary angioplasties must overcome, particularly with the development of drug-eluting stents (DES) and new devices and strategies for these challenging lesions. However, there is little information on the safety, efficacy, and real clinical benefit of implanting stents of over 60 mm (known as full metal jackets, FMJ)....
SOLACI CACI 2017 | Re-entry approach to CTO
Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Luiz Fernando Ybarra, entitled “Re-entry approach to CTO”. We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.
SOLACI CACI 2017 | CTO y CHIP Toolbox: Anatomía y Diseño de Guías Coronarias y MicroCatheters 101: Ingeniería para el Intervencionista”.
Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Dimitrios Karmpaliotis, entitled “CTO y CHIP Toolbox: Anatomía y Diseño de Guías Coronarias y MicroCatheters 101: Ingeniería para el Intervencionista”. We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.